95 results on '"Kaltenbach, Lisa A."'
Search Results
2. Abstract 341: Regional Variation in Cardiac Arrest Response and Outcomes in North Carolina - A Call to Action
3. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation
4. CHARACTERIZING THE DIGITAL DIVIDE & ACCESS TO MOBILE HEALTH INTERVENTIONS IN HEART FAILURE: INSIGHTS FROM THE CONNECT-HF MHEALTH SUBSTUDY
5. ADJUSTMENT OF GUIDELINE-DIRECTED MEDICAL THERAPY ONE YEAR POST-HEART FAILURE HOSPITALIZATION FALLS SHORT: INSIGHTS FROM THE CONNECT-HF TRIAL
6. Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) – Diabetes: rationale and design
7. Comparing the Classification of Percutaneous Coronary Interventions Using the 2012 and 2017 Appropriate Use Criteria: Insights From 245,196 Patients in the NCDR CathPCI Registry
8. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation
9. Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS
10. The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HF
11. Health System–Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial
12. EN-728-01 RACIAL AND ETHNIC INEQUITIES IN ORAL ANTICOAGULATION AND ASSOCIATED OUTCOMES FOR PATIENTS WITH ATRIAL FIBRILLATION - THE GET WITH THE GUIDELINES ATRIAL FIBRILLATION REGISTRY
13. CE-539-01 RACIAL AND ETHNIC INEQUITIES IN ORAL ANTICOAGULATION AND ASSOCIATED OUTCOMES FOR PATIENTS WITH ATRIAL FIBRILLATION - THE GET WITH THE GUIDELINES ATRIAL FIBRILLATION REGISTRY
14. Performance On Guideline Directed Medical Therapy Remains Low In A Cluster-randomized Trial: Results From CONNECT-HF
15. Patterns of Care for First-detected Atrial Fibrillation: Insights from the Get With The Guidelines Atrial Fibrillation Registry
16. Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
17. Abstract 10658: Patients Receive Better Care in a Traditional Randomized Trial Setting Than in a Pragmatic Quality Improvement Study: Potential Implications for Improvements in Care
18. Abstract 10159: Underuse of Evidence-based Therapies for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease: Insights from Clinical Research Networks in the United States
19. Trends in Use and Outcomes of Same-Day Discharge Following Elective Percutaneous Coronary Intervention
20. Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction
21. Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community
22. Characteristics and Outcomes of Patients With History of CABG Undergoing Cardiac Catheterization Via the Radial Versus Femoral Approach
23. Changes in Care Delivery for Patients with Heart Failure During the Covid-19 Pandemic: Results of a Multicenter Survey
24. Changes in Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter Survey
25. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes
26. Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill
27. Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs
28. SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE
29. Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF
30. Trends in Usage and Clinical Outcomes of Coronary Atherectomy
31. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications
32. Examining the Operator Learning Curve for Percutaneous Coronary Intervention of Chronic Total Occlusions
33. Safety of Dual‐Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease
34. Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women
35. THE ASSOCIATION OF P2Y12 INHIBITOR COPAYMENT REDUCTION WITH OUTCOMES AT HOSPITALS WITH AND WITHOUT MEDICATION ASSISTANCE PROGRAMS
36. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention
37. Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction
38. Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction
39. Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study
40. Adverse Change in Employment Status After Acute Myocardial Infarction
41. Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality
42. Hospital evaluation of health literacy and associated outcomes in patients after acute myocardial infarction
43. COMPARISON OF RATES OF BLEEDING AND VASCULAR COMPLICATIONS BEFORE, DURING, AND AFTER TRIAL ENROLLMENT IN THE SAFE-PCI TRIAL FOR WOMEN
44. Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE‐ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study
45. Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention
46. Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction
47. Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE‐ACS Study
48. Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study
49. TCT-605 Examining the Operator Learning Curve for Percutaneous Coronary Intervention of Chronic Total Occlusions
50. Magnitude and Characteristics of Patients Who Survived an Acute Myocardial Infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.